Medicare Enrolled
Dr. John Call, MD
Dermatology · San Ramon, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Call from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Call?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Call
Dr. John Call is a dermatology specialist in San Ramon, CA, with 9 years of NPI registration. Based on federal Medicare data, Dr. Call performed 14,703 Medicare services across 4,375 unique beneficiaries.
Between the years covered by Open Payments, Dr. Call received a total of $44,237 from 30 pharmaceutical and/or device companies across 556 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Call is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 9 years in practice
▲ Top 4% volume in CA
$44,237 industry payments
Medicare Practice Summary
Medicare Utilization ↗14,703
Medicare services
Top 4% in CA for dermatology
4,375
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,634 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, tildrakizumab, 1 mg | 5,900 | $110 | $167 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
2,928 | $7 | $17 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,906 | $77 | $217 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
887 | $47 | $165 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
526 | $87 | $268 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
478 | $108 | $293 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
268 | $13 | $34 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
261 | $53 | $136 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
207 | $1 | $10 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
204 | $89 | $265 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
163 | $51 | $135 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
138 | $5 | $12 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
126 | $113 | $306 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
102 | $301 | $780 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
102 | $164 | $447 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
83 | $124 | $619 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
41 | $42 | $141 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
39 | $2 | $10 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
38 | $166 | $418 |
| Chemotherapy administration, 1-7 injections This procedure involves the administration of chemotherapy medication through one to seven separate injections. |
35 | $77 | $221 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
29 | $118 | $306 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
28 | $95 | $374 |
| Intermediate wound repair, 2.5 cm or less This procedure involves stitching a wound on the scalp, underarms, trunk, arms, or legs that is 2.5 centimeters or smaller. It includes cleaning the wound and closing it with sutures to promote healing. |
27 | $262 | $672 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
23 | $124 | $334 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
21 | $73 | $250 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring 1.1 to 2.0 centimeters from the scalp, neck, hands, feet, or genitals. |
19 | $135 | $637 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 19 | $186 | $471 |
| Intermediate wound repair, 2.5 cm or less A medical procedure to close a wound on the neck, hands, feet, or genitals that is 2.5 centimeters or smaller. It involves cleaning the area and stitching the skin layers to promote healing. |
15 | $246 | $673 |
| Destruction of cancerous skin growth on face, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 0.6 and 1.0 centimeters in diameter. |
14 | $160 | $447 |
| Destruction of cancerous skin growth on face, 1.1-2.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 1.1 and 2.0 centimeters in diameter. |
14 | $200 | $511 |
| Surgical removal of skin cancer, 2.1-3.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters. |
13 | $140 | $697 |
| Intermediate wound repair, 2.6-7.5 cm This procedure involves stitching a wound on the neck, hands, feet, or genitals that measures between 2.6 and 7.5 centimeters. It is classified as an intermediate repair requiring layered closure. |
13 | $260 | $781 |
| Destruction of cancerous skin growth, 2.1-3.0 cm This procedure involves the removal or destruction of a cancerous skin lesion measuring between 2.1 and 3.0 centimeters located on the trunk, arms, or legs. |
13 | $188 | $482 |
| Skin cancer growth removal, 0.6-1.0 cm This procedure involves the surgical removal of a cancerous skin growth located on the body, arms, or legs. The size of the growth being removed is between 0.6 and 1.0 centimeters. |
12 | $116 | $580 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
11 | $133 | $392 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$44,237
Total received (2019-2024)
Avg $7,373/year across 6 years
Top 7% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
556
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$33,345 (75.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,892 (24.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$23,807
2023
$16,448
2022
$2,653
2021
$971
2020
$83
2019
$274
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$10,468
Regeneron Healthcare Solutions, Inc.
$9,552
ABBVIE INC.
$716
Lilly USA, LLC
$646
Incyte Corporation
$444
Arcutis Biotherapeutics, Inc.
$340
Novartis Pharmaceuticals Corporation
$219
Ortho Dermatologics, a division of Bausch Health US, LLC
$206
Janssen Biotech, Inc.
$194
SUN PHARMACEUTICAL INDUSTRIES INC.
$173
Dermavant Sciences, Inc.
$138
UCB, Inc.
$135
Galderma Laboratories, L.P.
$93
Amgen Inc.
$92
LEO Pharma Inc.
$75
Boehringer Ingelheim Pharmaceuticals, Inc.
$70
PFIZER INC.
$67
Fresenius Kabi USA, LLC
$64
Almirall LLC
$54
E.R. Squibb & Sons, L.L.C.
$44
STRATA Skin Sciences, Inc.
$16
Top 3 companies account for 87.1% of 2024 payments
All-time payments by company (2019-2024) ›
GENZYME CORPORATION
$18,855
Regeneron Healthcare Solutions, Inc.
$15,301
ABBVIE INC.
$1,332
Lilly USA, LLC
$1,301
AbbVie Inc.
$953
Incyte Corporation
$671
Novartis Pharmaceuticals Corporation
$623
Sun Pharmaceutical Industries Inc.
$602
Ortho Dermatologics, a division of Bausch Health US, LLC
$498
Arcutis Biotherapeutics, Inc.
$488
Janssen Biotech, Inc.
$436
UCB, Inc.
$418
E.R. Squibb & Sons, L.L.C.
$394
SUN PHARMACEUTICAL INDUSTRIES INC.
$384
Amgen Inc.
$327
Dermavant Sciences, Inc.
$315
Journey Medical Corporation
$273
Boehringer Ingelheim Pharmaceuticals, Inc.
$160
AbbVie, Inc.
$143
LEO Pharma Inc.
$131
Celgene Corporation
$131
Galderma Laboratories, L.P.
$106
PFIZER INC.
$95
Fresenius Kabi USA, LLC
$64
VYNE Pharmaceuticals Inc.
$61
Allergan, Inc.
$56
Almirall LLC
$54
Helsinn Therapeutics (U.S.), Inc.
$34
DERMIRA, INC.
$17
STRATA Skin Sciences, Inc.
$16
Top 3 companies account for 80.2% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · ARAZLO · Absorica LD · BOTOX · Bimzelx · CIBINQO · COSENTYX · Cabtreo · Cimzia · DUOBRII · DUPIXENT · EUCRISA · HUMIRA · IDACIO · ILUMYA · Ilumya · Klisyri · OLUMIANT · OPZELURA · Otezla · QBREXZA · REMICADE · RINVOQ · SILIQ · SKYRIZI · SPEVIGO · Skyrizi · Sotyktu · TALTZ · TREMFYA · VALCHLOR · VTAMA · Winlevi · XTRAC · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (75%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in dermatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for dermatology in CA.
Geographic Context
Dermatologists within 10 mi
285
Per 100K population
24.5
County median income
$125,727
Nearest hospital
SAN RAMON REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Call is a clinical cardiology specialist, with above-average Medicare volume (top 4% in CA), with speaking/promotional industry engagement in the top 7% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Call experienced with injection, tildrakizumab, 1 mg?
Based on Medicare claims data, Dr. Call performed 5,900 injection, tildrakizumab, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Call receive payments from pharmaceutical companies?
Yes. Dr. Call received a total of $44,237 from 30 companies across 556 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Call's costs compare to other dermatologists in San Ramon?
Dr. Call's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Call) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in San Ramon
Browse dermatologists in San Ramon ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in CA
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in CA
Which CA dermatologists receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology